ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Oncotelic Therapeutics Inc (QB)

Oncotelic Therapeutics Inc (QB) (OTLC)

0,0475
0,00
(0,00%)
Fermé 07 Juin 10:00PM

Oncotelic Therapeutics Inc (QB) (OTLC) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
0,0475
( - )
Prix Achat
0,01
Prix Vente
0,10
Volume échangé
71 397
0,0475 Fourchette du Jour 0,049975
0,015 Plage de 52 semaines 0,11
Cap du marché
Clôture Veille
0,0475
Ouverture
0,0475
Dernière Transaction
6000
@
0.0475
Dernière heure de transaction
Volume financier
US$ 3 410
VWAP
0,04776
Volume moyen (3 m)
US$ 304 368
Actions en circulation
443 477 729
Rendement du Dividende (LTM)
Ratio Cours sur Bénéfices
0,09
Bénéfice par action (BPA)
0,58
Chiffre d'affairess (LTM)
-
Bénéfice net (LTM)
247,38M

À propos de Oncotelic Therapeutics Inc (QB)

Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment of orphan oncology indications in the United States. The company develops antisense and small molecule injectable drugs for the treatment of cancer. It is also developing O... Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment of orphan oncology indications in the United States. The company develops antisense and small molecule injectable drugs for the treatment of cancer. It is also developing OXi4503 for the treatment of acute myeloid leukemia and myelodysplastic syndromes; OT-101, an antisense against TGF-ß2, which is in phase 3 clinical trials for pancreatic cancer, melanoma, and glioblastoma, as well as for the treatment of various viruses, including severe acute respiratory syndrome and coronavirus. In addition, the company develops CA4P for the treatment of advanced metastatic melanoma; AL-101, an intranasal drug and delivery system for intra-nasal apomorphine for the treatment of parkinson’s disease, erectile disfunction, and female sexual disfunction; Artemisinin, a natural derivative from an Asian herb Artemisia Annua; and AI based technologies to enhance the development and commercialization of support technologies, as well as nanoparticle products for the treatment of various cancers. The company is based in Agoura Hills, California. Show more

Secteur
Healthcare
Industrie
Biotechnology & Life Sciences
Siège social
Agoura Hills, United States
Fondé
-
Oncotelic Therapeutics Inc (QB) est coté dans le secteur Healthcare de la OTC Markets avec le ticker OTLC. Le dernier cours de clôture d'Oncotelic Therapeutics (QB) était de US$0,05. Au cours de la dernière année, les actions de Oncotelic Therapeutics (QB) ont été négociées dans une fourchette de prix de US$ 0,015 à US$ 0,11.

Oncotelic Therapeutics (QB) compte actuellement 443 477 729 actions en circulation. La capitalisation boursière d'Oncotelic Therapeutics (QB) est de US$21,07 million. Oncotelic Therapeutics (QB) a un ratio cours/bénéfice (ratio PE) de 0.09.

OTLC Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.01375-22.44897959180.061250.061250.0372521630.05141755CS
40.00923.37662337660.03850.0620.0363837930.05007364CS
120.007518.750.040.0620.02943179530.04219546CS
26-0.0431-47.57174392940.09060.1010.0152709380.04949275CS
52-0.01225-20.50209205020.059750.110.0152408900.0620595CS
1560.016553.22580645160.0310.110.011898840.04414639CS
260-0.2315-82.97491039430.2790.280.011897250.07594435CS

OTLC - Frequently Asked Questions (FAQ)

What is the current Oncotelic Therapeutics Inc (QB) share price?
The current share price of Oncotelic Therapeutics Inc (QB) is US$ 0,0475
How many Oncotelic Therapeutics Inc (QB) shares are in issue?
Oncotelic Therapeutics Inc (QB) has 443 477 729 shares in issue
What is the market cap of Oncotelic Therapeutics Inc (QB)?
The market capitalisation of Oncotelic Therapeutics Inc (QB) is USD 21,07M
What is the 1 year trading range for Oncotelic Therapeutics Inc (QB) share price?
Oncotelic Therapeutics Inc (QB) has traded in the range of US$ 0,015 to US$ 0,11 during the past year
What is the PE ratio of Oncotelic Therapeutics Inc (QB)?
The price to earnings ratio of Oncotelic Therapeutics Inc (QB) is 0,09
What is the registered address of Oncotelic Therapeutics Inc (QB)?
The registered address for Oncotelic Therapeutics Inc (QB) is 29397 Agoura Road, Agoura Hills, California, 91301
What is the Oncotelic Therapeutics Inc (QB) website address?
The website address for Oncotelic Therapeutics Inc (QB) is www.oncotelic.com
Which industry sector does Oncotelic Therapeutics Inc (QB) operate in?
Oncotelic Therapeutics Inc (QB) operates in the Biotechnology & Life Sciences sector

OTLC Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock